The European active surveillance study on OC [oral contraceptive] prescribing practice, benefits and safety (EURAS)

Trial Profile

The European active surveillance study on OC [oral contraceptive] prescribing practice, benefits and safety (EURAS)

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Feb 2010

At a glance

  • Drugs Drospirenone/ethinylestradiol (Primary) ; Ethinylestradiol/levonorgestrel; Oral contraceptives
  • Indications Pregnancy
  • Focus Adverse reactions
  • Acronyms EURAS-OC
  • Most Recent Events

    • 17 Dec 2009 Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma added as trial sponsors as reported by ClinicalTrials.gov.
    • 06 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top